Jubilant Ingrevia Limited (NSE: JUBLINGREA) is an integrated pharmaceutical and life sciences company headquartered in Noida, India. The company operates in the specialty chemicals, life sciences, and pharma segments. Jubilant Ingrevia has manufacturing facilities in India and North America and a global sales network covering over 100 countries. The company’s customers include major pharmaceutical, agrochemical, and other industrial companies worldwide.
For the quarter ended December 31, 2022, Jubilant Ingrevia reported a consolidated revenue of ₹1,152.63 crore, down 10% YoY. The company’s Net profit for the quarter stood at ₹91.53 crore, down 29% YoY, while its Earnings per share for the quarter was ₹5.75.
The Specialty Chemicals segment increased 14% year on year, while the Nutrition & Health Solutions and Chemical intermediates segments grew by 5% and -25%, respectively.